Q3 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ACST | Acasti Pharma | 0.63 | 0.07 | 12.49% | 113.2M |
You can purchase shares of Acasti Pharma (NASDAQ: ACST) through any online brokerage.
Other companies in Acasti Pharma’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cocrystal Pharma (NASDAQ:COCP).
The latest price target for Acasti Pharma (NASDAQ: ACST) was reported by Aegis Capital on 2020-09-02. The analyst firm set a price target for 0.25 expecting ACST to fall to within 12 months (a possible -60.34% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Acasti Pharma (NASDAQ: ACST) is $0.6304 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Acasti Pharma.
There is no upcoming split for Acasti Pharma.